SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-139456
Filing Date
2024-05-15
Accepted
2024-05-15 16:49:48
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d828180ds3.htm S-3 435084
2 EX-1.2 d828180dex12.htm EX-1.2 232757
3 EX-5.1 d828180dex51.htm EX-5.1 75590
4 EX-23.3 d828180dex233.htm EX-23.3 1663
5 EX-FILING FEES d828180dexfilingfees.htm EX-FILING FEES 47917
6 GRAPHIC g828180g31s21.jpg GRAPHIC 6267
7 GRAPHIC g828180g79y84.jpg GRAPHIC 39489
8 GRAPHIC g828180g82f28.jpg GRAPHIC 4702
  Complete submission text file 0001193125-24-139456.txt   864100
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279433 | Film No.: 24952134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)